DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Loomba R, Noureddin M, Kowdley KV. et al; ATLAS Investigators.
Combination therapies including cilofexor and firsocostat for bridging fibrosis and cirrhosis attributable to NASH.
Hepatology 2021;
73 (02) 625-643
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.